Here are relevant reports on : artificial-intelligence-drug-discovery-market
-
Artificial Intelligence in Genomics Market by Offering (Software & Services), Technology (Machine Learning), Functionality (Gene Sequencing, Gene Editing), Application (Diagnostics, Drug discovery), End User (Pharma, Hospitals) - Global Forecast to 2028
The global artificial intelligence in genomics market, valued at US$0.4 billion in 2022, stood at US$0.5 billion in 2024 and is projected to advance at a resilient CAGR of 32.3% from 2024 to 2028, culminating in a forecasted valuation of US$2.0 billion by the end of the period. The growth in this market is predominantly driven by the need to accelerate processes and timelines, reduce costs of drug development and discovery, and improve computing power through declining hardware costs.
- Published: May 2023
- Price: $ 4950
- TOC Available:
-
Anomaly Detection Market by Solution (Network and User Behavior Anomaly Detection), Technology (Big Data Analytics, Data Mining and Business Intelligence, Machine Learning and Artificial Intelligence), Deployment, Service, Vertical - Global Forecast to 2022
The anomaly detection market size is expected to grow from USD 2.08 Billion in 2017 to USD 4.45 Billion by 2022, at a Compound Annual Growth Rate (CAGR) of 16.4%. The major vendors in the anomaly detection market include Wipro Limited (India), Cisco Systems, Inc. (US), International Business Machines Corporation (US), Hewlett Packard Enterprise Company (US), Dell Technologies, Inc. (US), SAS Institue, Inc. (US), Symantec Corporation (US), Anodot (Israel), Happiest Minds (India), and Guardian Analytics (US).
- Published: August 2017
- Price: $ 4950
- TOC Available:
-
Drug Discovery Outsourcing Market - 2019 By Types, Application & Geography
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Top 10 Drug Discovery Technologies Market – Strategic Analysis and Global Forecasts (2010 to 2015)
The top 10 drug discovery technologies play a vital role in the growth of the entire pharmaceutical industry as they are the key contributors in the swift introduction of blockbusters and innovative drugs, which is the most important aspect for the pharmaceutical companies.
- Published: November 2010
- Price: $ 4950
- TOC Available:
-
Preclinical Models In Drug Discovery & Development Market - 2019 By Types, Application & Geography
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Drug Discovery Informatics Market by Function (Target Data, Sequencing Data Analysis, Docking), Solution (Software, Services), Application (Drug Development), End User (Pharmaceutical, Biotechnology, Contract Research Organizations) & Region - Global Forecast to 2025
The global drug discovery informatics market growth is primed to transition from $2.2 billion in 2020 to $3.5 billion by 2025, showcasing a strong CAGR of 9.3%. The market is primarily driven by increased R&D spending, especially in rare diseases, and the growing adoption of informatics in drug discovery.
- Published: April 2020
- Price: $ 4950
- TOC Available:
-
Life Science Analytics Market by Type (Descriptive, Prescriptive, Predictive), by Service (Analytics), Application (Drug Discovery, Trials, RWE, Access, Sales & Marketing, Drug Safety), End User (Pharma, Medical Device) & Region - Global Forecast to 2030
Global life science analytics market valued at $35.69B in 2024, reached $40.03B in 2025, and is projected to grow at a robust 11.4% CAGR, hitting $68.81B by 2030. Emerging technologies like artificial intelligence (AI), quantum computing, and cognitive computing play a vital role in transforming large volumes of raw data into actionable insights.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Chemoinformatics Market by Application (Chemical Analysis (Chemical Databases, Chemo Metrics, Molecular Modelling), Drug Discovery (High Throughput Screening, Lead Identification and Optimization, QSAR/QSPR), Drug Validation) - Global Forecast to 2023
Growth of the chemoinformatics market is primarily driven by innovations and advancements in the drug development process, advances in the computer technology, increased demand of personalized medicine. On the other hand, cost associated with the chemoinformatics software is one of the major factors restraining the growth of this market. Whereas emerging markets are expected to provide significant growth opportunities in this market.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Artificial Intelligence (AI) Market by Infrastructure (Compute, Memory, Networking, Storage), Software (Conversational Assistants, No Code/Low Code, BI & Analytics, Developer Platforms), Technology (ML, NLP, Generative AI) - Forecast to 2032
The Asia Pacific artificial intelligence (AI) market size is projected to reach 815.98 billion by 2032. The Key Players include Baidu (China), Alibaba Cloud (China), Huawei (China), Microsoft (US), AMD (US), Qualcomm (US), NVIDIA (US), Intel (US), Google (US), Appier (Taiwan), SenseTime (China), Oracle (US), IBM (US), along with startups/SMEs such as Advance.ai (Singapore) and Cinnamon AI (Japan).
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Industrial Metaverse Market by Technology (Digital Twin, Augmented Reality, Virtual Reality, Artificial Intelligence, Edge Computing, Private 5G, Blockchain), End User (Automotive, Aerospace, Electronics, Healthcare) and Region - Global Forecast to 2029
The global industrial metaverse market is expected to grow from USD 28.65 billion in 2024 to USD 228.54 billion by 2029, at a compound annual growth rate (CAGR) of 51.5%. during the forecast period.The key players NVIDIA Corporation (US), Microsoft (US), Siemens (Germany), Amazon Web Services, Inc. (US), IBM (US), Meta (US), HTC Corporation (Taiwan), ABB (Switzerland), PTC (US), Dassault Systèmes (France), GE Vernova (US), Intel Corporation (US), AVEVA Group Limited (UK), Alphabet, Inc. (US), and Nokia (Finland).
- Published: July 2024
- Price: $ 4950
- TOC Available:
Records 1 to 10 of 50
